InSite Vision to Present at the 8th Annual JMP Securities Healthcare Conference JMP Securities Healthcare Conference 2013 Business Wire ALAMEDA, Calif. -- July 2, 2013 InSite Vision Incorporated (OTCBB: INSV) today announced that Timothy Ruane, InSite’s Chief Executive Officer, will be presenting at the 8^th Annual JMP Securities Healthcare Conference on Tuesday, July 9, 2013, at 12:00 pm ET at the St. Regis Hotel in New York City, NY. A webcast of the presentation will be available on the investor section of InSite Vision’s website at www.insitevision.com and will be available for 30 days following the event. About InSite Vision InSite Vision is advancing new ophthalmologic products for unmet eye care needs based on its innovative DuraSite^® platform technologies. The DuraSite and DuraSite 2 drug delivery systems extend the duration of drug retention on the surface of the eye, thereby reducing the frequency of treatment and improving the efficacy of topical drugs. The DuraSite platform is currently leveraged in two commercial products for the treatment of bacterial eye infections, AzaSite^® (azithromycin ophthalmic solution) 1%, marketed in the U.S. by Merck, and Besivance^® (besifloxacin ophthalmic suspension) 0.6%, marketed by Bausch + Lomb. InSite Vision is advancing three novel ophthalmic therapeutics through Phase 3 clinical studies: AzaSite Plus^™ and DexaSite^™ for the treatment of eye infections, and BromSite^™ for pain and inflammation associated with ocular surgery. For further information on InSite Vision, please visit www.insitevision.com. AzaSite^®, DuraSite^® and DuraSite^® 2 are registered trademarks of InSite Vision Incorporated. AzaSite Plus^™, BromSite^™, and DexaSite^™ are trademarks of InSite Vision Incorporated. BESIVANCE^® is a registered trademark of Bausch + Lomb Incorporated. Contact: InSite Vision Louis Drapeau, 510-747-1220 Chief Financial Officer email@example.com or Media and Investor inquiries: BCC Partners Michelle Corral, 415-794-8668 Karen L. Bergman, 650-575-1509
InSite Vision to Present at the 8th Annual JMP Securities Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.